1. Home
  2. TSQ vs CLLS Comparison

TSQ vs CLLS Comparison

Compare TSQ & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSQ
  • CLLS
  • Stock Information
  • Founded
  • TSQ 1996
  • CLLS 1999
  • Country
  • TSQ United States
  • CLLS France
  • Employees
  • TSQ N/A
  • CLLS N/A
  • Industry
  • TSQ Broadcasting
  • CLLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • TSQ Consumer Discretionary
  • CLLS Health Care
  • Exchange
  • TSQ Nasdaq
  • CLLS Nasdaq
  • Market Cap
  • TSQ 131.9M
  • CLLS 148.1M
  • IPO Year
  • TSQ 2000
  • CLLS 2007
  • Fundamental
  • Price
  • TSQ $7.61
  • CLLS $1.29
  • Analyst Decision
  • TSQ Strong Buy
  • CLLS Buy
  • Analyst Count
  • TSQ 3
  • CLLS 3
  • Target Price
  • TSQ $16.83
  • CLLS $7.00
  • AVG Volume (30 Days)
  • TSQ 44.1K
  • CLLS 110.4K
  • Earning Date
  • TSQ 05-08-2025
  • CLLS 03-13-2025
  • Dividend Yield
  • TSQ 10.37%
  • CLLS N/A
  • EPS Growth
  • TSQ N/A
  • CLLS N/A
  • EPS
  • TSQ N/A
  • CLLS N/A
  • Revenue
  • TSQ $447,955,000.00
  • CLLS $36,042,000.00
  • Revenue This Year
  • TSQ N/A
  • CLLS $387.77
  • Revenue Next Year
  • TSQ $0.24
  • CLLS $11.14
  • P/E Ratio
  • TSQ N/A
  • CLLS N/A
  • Revenue Growth
  • TSQ N/A
  • CLLS 46.96
  • 52 Week Low
  • TSQ $7.57
  • CLLS $1.20
  • 52 Week High
  • TSQ $13.57
  • CLLS $3.38
  • Technical
  • Relative Strength Index (RSI)
  • TSQ 27.16
  • CLLS 39.45
  • Support Level
  • TSQ $7.85
  • CLLS $1.20
  • Resistance Level
  • TSQ $8.00
  • CLLS $1.32
  • Average True Range (ATR)
  • TSQ 0.26
  • CLLS 0.09
  • MACD
  • TSQ -0.06
  • CLLS 0.00
  • Stochastic Oscillator
  • TSQ 3.79
  • CLLS 25.71

About TSQ Townsquare Media Inc.

Townsquare Media Inc is a radio, digital media, entertainment, and digital marketing solutions company principally focused on being the premier local advertising and marketing solutions platform in small and mid-sized markets across the United States. It has three segments which are Subscription Digital Marketing Solutions, Digital Advertising, and Broadcast Advertising. It earns the majority of the revenue from the Broadcasting Advertising segment, which includes its local, regional, and national advertising products and solutions delivered via terrestrial radio broadcast. Its portfolio includes local media brands such as WYRK.com, WJON.com, and NJ101.5.com, and premier national music brands such as XXLmag.com, TasteofCountry.com, UltimateClassicRock.com, and Loudwire.com.

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.

Share on Social Networks: